• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

毒蕈碱受体上的正变构和负变构相互作用。

Positive and negative allosteric interactions on muscarinic receptors.

作者信息

Hejnová L, Tucek S, el-Fakahany E E

机构信息

Institute of Physiology, Academy of Sciences of the Czech Republic, Prague, Czech Republic.

出版信息

Eur J Pharmacol. 1995 Nov 30;291(3):427-30. doi: 10.1016/0922-4106(95)90085-3.

DOI:10.1016/0922-4106(95)90085-3
PMID:8719429
Abstract

It was previously found that alcuronium increases the binding of [3H]methyl-N-scopolamine to cardiac muscarinic receptors by a positive allosteric action while its effect on the binding of [3H]quinuclidinyl benzilate is negative. The, features of the antagonist's molecule which decide whether its allosteric interaction with alcuronium is positive or negative are not known. In the present work, it was found that alcuronium has a positive allosteric effect also on the binding of [3H]atropine and [3H]methyl-N-piperidinyl benzilate to muscarinic receptors in rat heart atria and that its effect on the binding of [3H]methyl-N-quinuclidinyl benzilate is negative. A comparison of the five radiolabelled antagonists that have been investigated so far indicates that the type of allosteric interaction (positive or negative) is not determined by the presence or absence of the quaternary nitrogen or of the benzilyl moiety in the molecule of the antagonist. Apparently, features of the N-bearing moiety of muscarinic antagonists other than the presence of a charge on nitrogen play a key role in the determination of the type of interaction.

摘要

先前发现,阿库氯铵通过正变构作用增加[3H]甲基-N-东莨菪碱与心脏毒蕈碱受体的结合,而其对[3H]喹核醇基苯甲酸酯结合的影响则为负性。决定其与阿库氯铵变构相互作用是正性还是负性的拮抗剂分子特征尚不清楚。在本研究中,发现阿库氯铵对[3H]阿托品和[3H]甲基-N-哌啶基苯甲酸酯与大鼠心房毒蕈碱受体的结合也有正变构效应,而其对[3H]甲基-N-喹核醇基苯甲酸酯结合的影响为负性。对目前已研究的五种放射性标记拮抗剂的比较表明,变构相互作用的类型(正性或负性)并非由拮抗剂分子中是否存在季铵氮或苯甲酰基部分所决定。显然,毒蕈碱拮抗剂含氮部分的特征(而非氮上的电荷)在决定相互作用类型方面起关键作用。

相似文献

1
Positive and negative allosteric interactions on muscarinic receptors.毒蕈碱受体上的正变构和负变构相互作用。
Eur J Pharmacol. 1995 Nov 30;291(3):427-30. doi: 10.1016/0922-4106(95)90085-3.
2
Subtype selectivity of the positive allosteric action of alcuronium at cloned M1-M5 muscarinic acetylcholine receptors.阿库氯铵对克隆的M1 - M5毒蕈碱型乙酰胆碱受体正向变构作用的亚型选择性。
J Pharmacol Exp Ther. 1995 Sep;274(3):1077-83.
3
[3H]tricyclopinate binding to brain muscarinic acetylcholine receptors: a comparison with [3H]quinuclidinyl benzilate.[3H]三环哌酯与脑毒蕈碱型乙酰胆碱受体的结合:与[3H]喹核醇基苯甲酸酯的比较。
Pharmacol Res. 1996 Apr-May;33(4-5):283-9. doi: 10.1006/phrs.1996.0040.
4
Positive allosteric action of alcuronium on solubilized cardiac muscarinic receptors.阿库氯铵对溶解的心肌毒蕈碱受体的正变构作用。
Neurochem Int. 1995 Oct-Nov;27(4-5):337-43. doi: 10.1016/0197-0186(95)00015-z.
5
Effects of an agonist, allosteric modulator, and antagonist on guanosine-gamma-[35S]thiotriphosphate binding to liposomes with varying muscarinic receptor/Go protein stoichiometry.激动剂、变构调节剂和拮抗剂对鸟苷-γ-[35S]硫代三磷酸与具有不同毒蕈碱受体/Go蛋白化学计量比的脂质体结合的影响。
Mol Pharmacol. 1998 Nov;54(5):899-906. doi: 10.1124/mol.54.5.899.
6
Positive cooperativity in the binding of alcuronium and N-methylscopolamine to muscarinic acetylcholine receptors.阿库氯铵和N-甲基东莨菪碱与毒蕈碱型乙酰胆碱受体结合中的正协同性。
Mol Pharmacol. 1990 Nov;38(5):674-80.
7
Protection by alcuronium of muscarinic receptors against chemical inactivation and location of the allosteric binding site for alcuronium.
J Neurochem. 1994 Nov;63(5):1932-40. doi: 10.1046/j.1471-4159.1994.63051932.x.
8
Opposite effects of alcuronium on agonist and on antagonist binding to muscarinic receptors.阿库氯铵对激动剂及拮抗剂与毒蕈碱受体结合的相反作用。
Eur J Pharmacol. 1996 Jun 3;305(1-3):231-4. doi: 10.1016/0014-2999(96)00240-3.
9
Competition between positive and negative allosteric effectors on muscarinic receptors.毒蕈碱受体上正性和负性变构效应剂之间的竞争
Mol Pharmacol. 1995 Oct;48(4):696-702.
10
Positive allosteric interactions on cardiac muscarinic receptors: effects of chemical modifications of disulphide and carboxyl groups.心脏毒蕈碱受体上的正变构相互作用:二硫键和羧基化学修饰的影响
Eur J Pharmacol. 1995 Apr 28;289(2):311-9. doi: 10.1016/0922-4106(95)90109-4.

引用本文的文献

1
Seven transmembrane receptors as shapeshifting proteins: the impact of allosteric modulation and functional selectivity on new drug discovery.七跨膜受体作为构象变化蛋白:变构调节和功能选择性对新药发现的影响。
Pharmacol Rev. 2010 Jun;62(2):265-304. doi: 10.1124/pr.108.000992. Epub 2010 Apr 14.
2
Allosteric modulation of muscarinic acetylcholine receptors.变构调节毒蕈碱型乙酰胆碱受体。
Curr Neuropharmacol. 2007 Sep;5(3):157-67. doi: 10.2174/157015907781695946.
3
Allosteric drugs acting at muscarinic acetylcholine receptors.作用于毒蕈碱型乙酰胆碱受体的变构药物。
Neurochem Res. 2003 Apr;28(3-4):419-22. doi: 10.1023/a:1022888332221.
4
Interactions between allosteric modulators and 4-DAMP and other antagonists at muscarinic receptors: potential significance of the distance between the N and carboxyl C atoms in the molecules of antagonists.变构调节剂与4-二甲基氨基吡啶及其他毒蕈碱受体拮抗剂之间的相互作用:拮抗剂分子中氮原子与羧基碳原子之间距离的潜在意义。
Neurochem Res. 2001 Apr;26(4):383-94. doi: 10.1023/a:1010951131496.